- Home
- HTCR vs DYAI Comparison
HTCR vs DYAI Comparison
Compare HTCR & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTCR
- DYAI
- Stock Information
- Founded
- HTCR 2009
- DYAI 1979
- Country
- HTCR Japan
- DYAI United States
- Employees
- HTCR N/A
- DYAI N/A
- Industry
- HTCR EDP Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HTCR Technology
- DYAI Health Care
- Exchange
- HTCR Nasdaq
- DYAI Nasdaq
- Market Cap
- HTCR 48.1M
- DYAI 54.4M
- IPO Year
- HTCR 2022
- DYAI 2004
- Fundamental
- Price
- HTCR $1.49
- DYAI $1.50
- Analyst Decision
- HTCR
- DYAI Strong Buy
- Analyst Count
- HTCR 0
- DYAI 1
- Target Price
- HTCR N/A
- DYAI $6.00
- AVG Volume (30 Days)
- HTCR 738.4K
- DYAI 213.3K
- Earning Date
- HTCR 11-14-2024
- DYAI 11-12-2024
- Dividend Yield
- HTCR 5.37%
- DYAI N/A
- EPS Growth
- HTCR N/A
- DYAI N/A
- EPS
- HTCR 0.23
- DYAI N/A
- Revenue
- HTCR $30,290,930.00
- DYAI $3,364,548.00
- Revenue This Year
- HTCR $53.30
- DYAI $51.30
- Revenue Next Year
- HTCR N/A
- DYAI $73.26
- P/E Ratio
- HTCR $6.41
- DYAI N/A
- Revenue Growth
- HTCR 47.63
- DYAI 13.82
- 52 Week Low
- HTCR $0.45
- DYAI $0.93
- 52 Week High
- HTCR $3.38
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- HTCR 45.72
- DYAI 42.12
- Support Level
- HTCR $1.53
- DYAI $1.45
- Resistance Level
- HTCR $1.76
- DYAI $1.79
- Average True Range (ATR)
- HTCR 0.39
- DYAI 0.24
- MACD
- HTCR -0.06
- DYAI -0.05
- Stochastic Oscillator
- HTCR 1.31
- DYAI 7.25
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.